Cresco Labs (CRLBF) Cost of Revenue (2020 - 2026)

Cresco Labs' Cost of Revenue history runs 7 years deep, the most recent figure standing at $75.9 million for Q1 2026.

• Quarterly Cost of Revenue fell 12.91% year-over-year to $75.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $320.0 million (down 9.83% YoY) and the FY2025 annual result came in at $331.3 million, down 7.95% from the prior year.
• Cost of Revenue was $75.9 million for Q1 2026 at Cresco Labs, down from $78.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $111.9 million in Q4 2022 and bottomed at $75.9 million in Q1 2026.
• A 5-year average of $94.8 million and a median of $92.1 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 30.83% — and 2024, when it retreated 19.43%.
• Cresco Labs' Cost of Revenue stood at $111.9 million in 2022, then slipped by 17.68% to $92.1 million in 2023, then retreated by 0.23% to $91.9 million in 2024, then decreased by 14.86% to $78.2 million in 2025, then retreated by 3.01% to $75.9 million in 2026.
• Business Quant data shows CRLBF's Cost of Revenue at $75.9 million in Q1 2026, $78.2 million in Q4 2025, and $85.6 million in Q3 2025.